Literature DB >> 7767843

Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats.

R T Turner1, K S Hannon, V S Greene, N H Bell.   

Abstract

Prednisone inhibits bone formation and causes bone loss. To investigate possible mechanisms and sites, the effects of sham operation, ovariectomy, and prednisone were determined on bone and mineral metabolism in 7-week-old growing female rats. Forty animals were divided into groups of 10 each. Sham operation and ovariectomy were performed. One week later, pellets containing 5 mg prednisone or drug free were implanted S.C. at the back of the neck. Four weeks later, animals were sacrificed and tibiae were removed for histomorphometric analysis of the middiaphysis and proximal metaphysis. In both sham-operated and ovariectomized rats, prednisone (1) reduced weight gain (P < 0.02) and did not alter uterine weight; (2) lowered serum magnesium (Mg) (P < 0.001) and did not change serum calcium (Ca), phosphate (P), 25-hydroxyvitamin D (25OHD), or 1,25-dihydroxyvitamin D [1,25(OH)2D]; (3) produced striking increases in calcified cartilage, reduced cross-sectional area (P < 0.05) and cortical area (P < 0.01) and did not change medullary area of the tibial diaphysis; (4) lowered periosteal and endocortical bone formation and apposition rates; and (5) increased mean cancellous bone area (P < 0.05) and cancellous bone perimeter (P < 0.01) of the tibial metaphysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7767843     DOI: 10.1007/BF00318052

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

1.  A rapid assay for 25-OH-vitamin D3 without preparative chromatography.

Authors:  R E Belsey; H F DeLuca; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

2.  Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.

Authors:  R T Turner; G K Wakley; K S Hannon; N H Bell
Journal:  Endocrinology       Date:  1988-03       Impact factor: 4.736

3.  Cortisol decreases bone formation by inhibiting periosteal cell proliferation.

Authors:  Y S Chyun; B E Kream; L G Raisz
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

4.  Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3.

Authors:  J U Lindgren; O Johnell; H F DeLuca
Journal:  Clin Orthop Relat Res       Date:  1983-12       Impact factor: 4.176

5.  Effect of 1,25-dihydroxyvitamin D3 on osteopenia induced by prednisolone in adult rats.

Authors:  J U Lindgren; C R Merchant; H F DeLuca
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

6.  Effects of menatetrenone on prednisolone-induced bone loss in rats.

Authors:  K Hara; Y Akiyama; I Ohkawa; T Tajima
Journal:  Bone       Date:  1993 Nov-Dec       Impact factor: 4.398

7.  Temporal relationship between bone loss and increased bone turnover in ovariectomized rats.

Authors:  T J Wronski; M Cintrón; L M Dann
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

8.  The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats.

Authors:  R T Turner; J J Vandersteenhoven; N H Bell
Journal:  J Bone Miner Res       Date:  1987-04       Impact factor: 6.741

9.  Stimulation by glucocorticoids of the differentiated phenotype of chondrocytes and the proliferation of rabbit costal chondrocytes in culture.

Authors:  T Takano; M Takigawa; F Suzuki
Journal:  J Biochem       Date:  1985-04       Impact factor: 3.387

10.  Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease.

Authors:  D P Desimone; V S Greene; K S Hannon; R T Turner; N H Bell
Journal:  J Bone Miner Res       Date:  1993-05       Impact factor: 6.741

View more
  5 in total

Review 1.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

Review 2.  Endogenous Glucocorticoids and Bone.

Authors:  Hong Zhou; Mark S Cooper; Markus J Seibel
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

3.  Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells.

Authors:  S Warabi; Y Tachibana; M Kumegawa; Y Hakeda
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

4.  Cortical Bone Porosity in Rabbit Models of Osteoporosis.

Authors:  Kim D Harrison; Beverly D Hiebert; Arash Panahifar; Janna M Andronowski; Amir M Ashique; Gavin A King; Terra Arnason; Kurtis J Swekla; Peter Pivonka; David Ml Cooper
Journal:  J Bone Miner Res       Date:  2020-09-22       Impact factor: 6.741

5.  Leptin Increases Particle-Induced Osteolysis in Female ob/ob Mice.

Authors:  Kenneth A Philbrick; Adam J Branscum; Carmen P Wong; Russell T Turner; Urszula T Iwaniec
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.